275 related articles for article (PubMed ID: 12438236)
1. Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Ho R; Eggert A; Hishiki T; Minturn JE; Ikegaki N; Foster P; Camoratto AM; Evans AE; Brodeur GM
Cancer Res; 2002 Nov; 62(22):6462-6. PubMed ID: 12438236
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
[TBL] [Abstract][Full Text] [Related]
3. Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB.
Evans AE; Kisselbach KD; Liu X; Eggert A; Ikegaki N; Camoratto AM; Dionne C; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):181-4. PubMed ID: 11464878
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Brodeur GM
Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
[TBL] [Abstract][Full Text] [Related]
5. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
Zhang JH; Li AM; Chen S; Tong HX; Zhang KR; Zhang JH
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):47-50. PubMed ID: 18289471
[TBL] [Abstract][Full Text] [Related]
6. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
Schulte JH; Schramm A; Klein-Hitpass L; Klenk M; Wessels H; Hauffa BP; Eils J; Eils R; Brodeur GM; Schweigerer L; Havers W; Eggert A
Oncogene; 2005 Jan; 24(1):165-77. PubMed ID: 15637590
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity.
Scala S; Wosikowski K; Giannakakou P; Valle P; Biedler JL; Spengler BA; Lucarelli E; Bates SE; Thiele CJ
Cancer Res; 1996 Aug; 56(16):3737-42. PubMed ID: 8706017
[TBL] [Abstract][Full Text] [Related]
8. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
Li Z; Jaboin J; Dennis PA; Thiele CJ
Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614
[TBL] [Abstract][Full Text] [Related]
9. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
[TBL] [Abstract][Full Text] [Related]
10. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
Matsumoto K; Wada RK; Yamashiro JM; Kaplan DR; Thiele CJ
Cancer Res; 1995 Apr; 55(8):1798-806. PubMed ID: 7712490
[TBL] [Abstract][Full Text] [Related]
11. The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness.
Hecht M; Schulte JH; Eggert A; Wilting J; Schweigerer L
Carcinogenesis; 2005 Dec; 26(12):2105-15. PubMed ID: 16051641
[TBL] [Abstract][Full Text] [Related]
12. Mixed-lineage kinase inhibitors require the activation of Trk receptors to maintain long-term neuronal trophism and survival.
Wang LH; Paden AJ; Johnson EM
J Pharmacol Exp Ther; 2005 Mar; 312(3):1007-19. PubMed ID: 15525794
[TBL] [Abstract][Full Text] [Related]
13. Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.
Schramm A; Schulte JH; Astrahantseff K; Apostolov O; Limpt Vv; Sieverts H; Kuhfittig-Kulle S; Pfeiffer P; Versteeg R; Eggert A
Cancer Lett; 2005 Oct; 228(1-2):143-53. PubMed ID: 15921851
[TBL] [Abstract][Full Text] [Related]
14. Nicotine regulates SH-SY5Y neuroblastoma cell proliferation through the release of brain-derived neurotrophic factor.
Serres F; Carney SL
Brain Res; 2006 Jul; 1101(1):36-42. PubMed ID: 16790237
[TBL] [Abstract][Full Text] [Related]
15. Acceleration of methylmercury-induced cell death of rat cerebellar neurons by brain-derived neurotrophic factor in vitro.
Sakaue M; Mori N; Makita M; Fujishima K; Hara S; Arishima K; Yamamoto M
Brain Res; 2009 Jun; 1273():155-62. PubMed ID: 19332029
[TBL] [Abstract][Full Text] [Related]
16. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.
Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM
Cancer Res; 2002 Mar; 62(6):1802-8. PubMed ID: 11912158
[TBL] [Abstract][Full Text] [Related]
17. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
[TBL] [Abstract][Full Text] [Related]
18. Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness.
Cimmino F; Schulte JH; Zollo M; Koster J; Versteeg R; Iolascon A; Eggert A; Schramm A
Oncogene; 2009 May; 28(19):2015-23. PubMed ID: 19363525
[TBL] [Abstract][Full Text] [Related]
19. Ethanol inhibits brain-derived neurotrophic factor-mediated intracellular signaling and activator protein-1 activation in cerebellar granule neurons.
Li Z; Ding M; Thiele CJ; Luo J
Neuroscience; 2004; 126(1):149-62. PubMed ID: 15145081
[TBL] [Abstract][Full Text] [Related]
20. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]